FLAM

First Light Asset Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 106.62%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+106.62%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.06B
AUM Growth
+$289M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1
+$31.6M
2
+$25.5M
3
+$24.1M
4
NEO icon
NeoGenomics
NEO
+$21.6M
5
AXGN icon
Axogen
AXGN
+$18.5M

Top Sells

1
+$58.5M
2
+$11.7M
3
+$9.24M
4
SENS icon
Senseonics Holdings Inc
SENS
+$8.55M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$7.86M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRON icon
26
Disc Medicine
IRON
$2.63B
$15.3M 1.44%
+231,186
VERA icon
27
Vera Therapeutics
VERA
$2.7B
$14.7M 1.39%
507,097
-55,884
NPCE icon
28
Neuropace
NPCE
$570M
$14M 1.32%
1,360,071
-20,339
CAI
29
Caris Life Sciences
CAI
$5.71B
$11.9M 1.12%
403,924
-39,119
SLP icon
30
Simulations Plus
SLP
$294M
$11.6M 1.09%
767,760
+410,603
RARE icon
31
Ultragenyx Pharmaceutical
RARE
$2.37B
$8.59M 0.81%
285,699
-262,206
ABVX
32
Abivax
ABVX
$9.08B
$8.15M 0.77%
+95,955
SENS icon
33
Senseonics Holdings Inc
SENS
$295M
$7.85M 0.74%
900,382
-885,024
RGEN icon
34
Repligen
RGEN
$6.63B
$5.54M 0.52%
41,427
-2,522
GPCR icon
35
Structure Therapeutics
GPCR
$3.22B
$5.53M 0.52%
197,350
+75,124
MDGL icon
36
Madrigal Pharmaceuticals
MDGL
$11.8B
$5.29M 0.5%
+11,539
EVH icon
37
Evolent Health
EVH
$349M
$4.61M 0.43%
545,282
-193,268
ALHC icon
38
Alignment Healthcare
ALHC
$4.32B
$3.54M 0.33%
203,138
-180,525
RDNT icon
39
RadNet
RDNT
$4.51B
$3.22M 0.3%
42,280
-26,414
TECX
40
Tectonic Therapeutic
TECX
$536M
$3.18M 0.3%
+202,393
BFLY icon
41
Butterfly Network
BFLY
$1.36B
$2.18M 0.21%
1,127,998
-4,337,034
INSM icon
42
Insmed
INSM
$29.2B
– –
-62,901
JANX icon
43
Janux Therapeutics
JANX
$913M
– –
-149,596
ELDN icon
44
Eledon Pharmaceuticals
ELDN
$262M
– –
-2,600,498
EOLS icon
45
Evolus
EOLS
$345M
– –
-520,631
LNTH icon
46
Lantheus
LNTH
$5.49B
– –
-30,045
XENE icon
47
Xenon Pharmaceuticals
XENE
$5.34B
– –
-188,367
1
2